Symposia: Aggressive Lymphomas: Pharmacologic Therapies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Combination therapy, Adult, Lymphomas, Bispecific Antibody Therapy, Non-Hodgkin lymphoma, Drug development, Clinical Research, B Cell lymphoma, Diseases, Aggressive lymphoma, Treatment Considerations, Biological therapies, Immunotherapy, Lymphoid Malignancies, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Combination therapy, Adult, Lymphomas, Bispecific Antibody Therapy, Non-Hodgkin lymphoma, Drug development, Clinical Research, B Cell lymphoma, Diseases, Aggressive lymphoma, Treatment Considerations, Biological therapies, Immunotherapy, Lymphoid Malignancies, Study Population, Human
Monday, December 9, 2024: 4:30 PM-6:00 PM
Pacific Ballroom Salons 18-19
(Marriott Marquis San Diego Marina)
Moderators:
Basem M. William, MD, MRCP(UK), FACP, OhioHealth
and
James B. Ford, DO, University of Nebraska Medical Center
Disclosures:
William: Morphosys: Consultancy; PPD/Orca: Consultancy; ADC Therapeutics: Consultancy; Guidepoint Global: Consultancy; Genmab: Consultancy; BMS: Consultancy.
This session focuses on novel combination therapies for relapsed or refractory aggressive lymphoma.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH